Sarcoidosis - Scientific progress and clinical challenges

Nature Reviews Rheumatology

Volumn 7, Issue 8, 2011, Pages 457-467

  Chen, Edward S ^a   Moller, David R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; ATORVASTATIN; AZATHIOPRINE; BIOLOGICAL MARKER; CHLOROQUINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYTOKINE; ETANERCEPT; HLA ANTIGEN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; RITUXIMAB; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR; USTEKINUMAB; VITAMIN D;

AUTOIMMUNITY; CYTOKINE PRODUCTION; EYE TOXICITY; FAMILY STUDY; GASTROINTESTINAL SYMPTOM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; KIDNEY CALCIFICATION; KIDNEY FAILURE; MAJOR HISTOCOMPATIBILITY COMPLEX; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROPIONIBACTERIUM; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SARCOIDOSIS; UNSPECIFIED SIDE EFFECT;

BACTERIAL INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; HUMANS; PROGNOSIS; SARCOIDOSIS;

EID: 80051471196     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.93     Document Type: Review

References (120)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am. J. Respir. Crit. Care Med. 160, 736-755 (1999).
2. Baughman, R. P. et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am. J. Respir. Crit. Care Med. 164, 1885-1889 (2001). (Pubitemid 33152325)
3. Iannuzzi, M. C., Rybicki, B. A. & Teirstein, A. S. Sarcoidosis. N. Engl. J. Med. 357, 2153-2165 (2007).
4. Rybicki, B. A. & Iannuzzi, M. C. Epidemiology of sarcoidosis: Recent advances and future prospects. Semin. Respir. Crit. Care Med. 28, 22-35 (2007). (Pubitemid 46371213)
5. Rybicki, B. A., Major, M., Popovich, J. Jr, Maliarik, M. J. & Iannuzzi, M. C. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am. J. Epidemiol. 145, 234-241 (1997).
6. Grunewald, J. & Eklund, A. Sex-specific manifestations of Löfgren's syndrome. Am. J. Respir. Crit. Care Med. 175, 40-44 (2007).
7. Judson, M. A. et al. Two year prognosis of sarcoidosis: The ACCESS experience. Sarcoidosis Vasc. Diffuse Lung Dis. 20, 204-211 (2003). (Pubitemid 37351542)
8. Girard, N. et al. Opportunistic infections and sarcoidosis [French]. Rev. Mal. Respir. 21, 1083-1090 (2004).
9. Romagnani, S. Regulation of the T cell response. Clin. Exp. Allergy 36, 1357-1366 (2006). (Pubitemid 44674119)
10. Welker, L., Jorres, R. A., Costabel, U. & Magnussen, H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur. Respir. J. 24, 1000-1006 (2004). (Pubitemid 39642292)
11. Zissel, G., Prasse, A. & Muller-Quernheim, J. Sarcoidosis- immunopathogenetic concepts. Semin. Respir. Crit. Care Med. 28, 3-14 (2007).
12. Moller, D. R. et al. Enhanced expression of IL-12 associated with TH1 cytokine profiles in active pulmonary sarcoidosis. J. Immunol. 156, 4952-4960 (1996). (Pubitemid 26174485)
13. Greene, C. M. et al. Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J. Immunol. 165, 4718-4724 (2000).
14. Larousserie, F. et al. Expression of IL-27 in human TH1-Associated granulomatous diseases. J. Pathol. 202, 164-171 (2004). (Pubitemid 38208653)
15. Ehrt, S. et al. Reprogramming of the macrophage transcriptome in response to interferon-? and Mycobacterium tuberculosis: Signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194, 1123-1140 (2001).
16. Agostini, C. et al. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol. 157, 910-918 (1996). (Pubitemid 26231399)
17. Rosenbaum, J. T. et al. Hypothesis: Sarcoidosis is a STAT1-mediated disease. Clin. Immunol. 132, 174-183 (2009).
18. Walker, C. et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir. Crit. Care Med. 150, 1038-1048 (1994). (Pubitemid 24318033)
19. Hauber, H. P., Gholami, D., Meyer, A. & Pforte, A. Increased interleukin-13 expression in patients with sarcoidosis. Thorax 58, 519-524 (2003). (Pubitemid 36714015)
20. Wiken, M. et al. No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis. Respir. Res. 11, 121 (2010).
21. Facco, M. et al. Sarcoidosis is a TH1/TH17 multisystem disorder. Thorax 66, 144-150 (2011).
22. Lenner, R., Bregman, Z., Teirstein, A. S. & DePalo, L. Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy. Chest 119, 978-981 (2001). (Pubitemid 32197681)
23. Airaghi, L., Montori, D., Zorzi, F., Miadonna, A. & Tedeschi, A. Sarcoidosis in a patient with 5q-myelodysplasia. A possible pathogenetic link between the two diseases. Monaldi Arch. Chest Dis. 55, 378-380 (2000). (Pubitemid 32101341)
24. Moller, D. R. Involvement of T cells and alterations in T cell receptors in sarcoidosis. Semin. Respir. Infect. 13, 174-183 (1998). (Pubitemid 28440836)
25. Grunewald, J. et al. Restricted V a 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J. Immunol. 22, 129-135 (1992).
26. Strausz, J. et al. Spontaneous monokine release by alveolar macrophages in chronic sarcoidosis. Int. Arch. Allergy Appl. Immunol. 96, 68-75 (1991).
27. Baughman, R. P. et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am. J. Respir. Crit. Care Med. 174, 795-802 (2006). (Pubitemid 44511661)
28. Culver, D. A. et al. Peroxisome proliferator-Activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis. Am. J. Respir. Cell Mol. Biol. 30, 1-5 (2004). (Pubitemid 38085252)
29. Miyara, M. et al. The immune paradox of sarcoidosis and regulatory T cells. J. Exp. Med. 203, 359-370 (2006). (Pubitemid 43290845)
30. Taflin, C. et al. FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am. J. Pathol. 174, 497-508 (2009).
31. Idali, F., Wahlstrom, J., Muller-Suur, C., Eklund, A. & Grunewald, J. Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis. Clin. Exp. Immunol. 152, 127-137 (2008). (Pubitemid 351347561)
32. Prasse, A. et al. Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis. Am. J. Respir. Crit. Care Med. 182, 540-548 (2010).
33. Ho, L. P., Urban, B. C., Thickett, D. R., Davies, R. J. & McMichael, A. J. Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis. Lancet 365, 1062-1072 (2005). (Pubitemid 40386784)
34. Mathew, S., Bauer, K. L., Fischoeder, A., Bhardwaj, N. & Oliver, S. J. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J. Immunol. 181, 746-755 (2008).
35. Veltkamp, M. et al. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: Functional effects and relevance to sarcoidosis. Clin. Exp. Immunol. 149, 453-462 (2007). (Pubitemid 47256146)
36. Wiken, M., Grunewald, J., Eklund, A. & Wahlstrom, J. Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J. Clin. Immunol. 29, 78-89 (2009).
37. Chen, E. S. et al. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am. J. Respir. Crit. Care Med. 181, 360-373 (2010).
38. Elias, J. A., Freundlich, B., Kern, J. A. & Rosenbloom, J. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 97, 1439-1445 (1990). (Pubitemid 20185694)
39. Zissel, G., Prasse, A. & Muller-Quernheim, J. Immunologic response of sarcoidosis. Semin. Respir. Crit. Care Med. 31, 390-403 (2010).
40. Henry, M. T. et al. Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur. Respir. J. 20, 1220-1227 (2002). (Pubitemid 35331881)
41. Prasse, A. et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am. J. Respir. Crit. Care Med. 173, 781-792 (2006).
42. Fernandez Fabrellas, E. Epidemiology of sarcoidosis [Spanish]. Arch. Bronconeumol. 43, 92-100 (2007).
43. Rybicki, B. A. et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am. J. Respir. Crit. Care Med. 164, 2085-2091 (2001). (Pubitemid 34020250)
44. Sverrild, A. et al. Heredity in sarcoidosis: A registry-based twin study. Thorax 63, 894-896 (2008).
45. Muller-Quernheim, J. et al. Genetics of sarcoidosis. Clin. Chest Med. 29, 391-414, viii (2008). (Pubitemid 351778209)
46. Rossman, M. D. et al. HLA-DRB1*1101: A significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet. 73, 720-735 (2003). (Pubitemid 37271878)
47. Voorter, C. E. et al. HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens 70, 18-27 (2007). (Pubitemid 46890274)
48. Berlin, M., Fogdell-Hahn, A., Olerup, O., Eklund, A. & Grunewald, J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 156, 1601-1605 (1997). (Pubitemid 27505531)
49. Sato, H. et al. HLA-DQB1*0201: A marker for good prognosis in British and Dutch patients with sarcoidosis. Am. J. Respir. Cell Mol. Biol. 27, 406-412 (2002).
50. Voorter, C. E., Drent, M. & van den Berg-Loonen, E. M. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602-DRB1*150101. Hum. Immunol. 66, 826-835 (2005). (Pubitemid 41169773)
51. Medica, I., Kastrin, A., Maver, A. & Peterlin, B. Role of genetic polymorphisms in ACE and TNF-A gene in sarcoidosis: A meta-Analysis. J. Hum. Genet. 52, 836-847 (2007). (Pubitemid 47512856)
52. Zorzetto, M. et al. Complement receptor 1 gene polymorphisms in sarcoidosis. Am. J. Respir. Cell Mol. Biol. 27, 17-23 (2002). (Pubitemid 34657386)
53. Schurmann, M. et al. CARD15 gene mutations in sarcoidosis. Eur. Respir. J. 22, 748-754 (2003). (Pubitemid 37369562)
54. Spagnolo, P. et al. A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Lofgren's syndrome. J. Intern. Med. 264, 433-441 (2008).
55. Sato, H. et al. CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis. Eur. Respir. J. 35, 324-330 (2010).
56. Campo, I. et al. Expression of receptor for advanced glycation end products in sarcoid granulomas. Am. J. Respir. Crit. Care Med. 175, 498-506 (2007). (Pubitemid 46354254)
57. Kruit, A., Ruven, H. J., Grutters, J. C. & van den Bosch, J. M. Angiotensin II receptor type 1 1166 A/C and angiotensin converting enzyme I/D gene polymorphisms in a Dutch sarcoidosis cohort. Sarcoidosis Vasc. Diffuse Lung Dis. 27, 147-152 (2010).
58. Rybicki, B. A., Maliarik, M. J., Poisson, L. M. & Iannuzzi, M. C. Sarcoidosis and granuloma genes: A family-based study in African-Americans. Eur. Resp. J. 24, 251-257 (2004). (Pubitemid 39139792)
59. Valentonyte, R. et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet. 37, 357-364 (2005).
60. Rybicki, B. A., Walewski, J. L., Maliarik, M. J., Kian, H. & Iannuzzi, M. C. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am. J. Hum. Genet. 77, 491-499 (2005). (Pubitemid 41192655)
61. Spagnolo, P. et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens 70, 219-227 (2007). (Pubitemid 47106649)
62. Hofmann, S. et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat. Genet. 40, 1103-1106 (2008).
63. Franke, A. et al. Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology 135, 1207-1215 (2008).
64. Rossman, M. D. et al. HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 25, 125-132 (2008).
65. Westney, G. E. & Judson, M. A. Racial and ethnic disparities in sarcoidosis: From genetics to socioeconomics. Clin. Chest Med. 27, 453-462, vi (2006). (Pubitemid 44160530)
66. Newman, L. S. et al. A case control etiologic study of sarcoidosis: Environmental and occupational risk factors. Am. J. Respir. Crit. Care Med. 170, 1324-1330 (2004). (Pubitemid 39657197)
67. Shaykhiev, R. et al. Smoking-dependent reprogramming of alveolar macrophage polarization: Implication for pathogenesis of chronic obstructive pulmonary disease. J. Immunol. 183, 2867-2883 (2009).
68. Kern, D. G., Neill, M. A., Wrenn, D. S. & Varone, J. C. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am. Rev. Respir. Dis. 148, 974-980 (1993). (Pubitemid 23301216)
69. Izbicki, G. et al. World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest 131, 1414-1423 (2007). (Pubitemid 46762347)
70. Crowley, L. E. et al. "Sarcoid like" granulomatous pulmonary disease in World Trade Center disaster responders. Am. J. Ind. Med. 54, 175-184 (2011).
71. Milman, N., Lisby, G., Friis, S. & Kemp, L. Prolonged culture for mycobacteria in mediastinal lymph nodes from patients with pulmonary sarcoidosis. A negative study. Sarcoidosis Vasc. Diffuse Lung Dis. 21, 25-28 (2004). (Pubitemid 38533810)
72. Gupta, D., Agarwal, R., Aggarwal, A. N. & Jindal, S. K. Molecular evidence for the role of mycobacteria in sarcoidosis: A meta-Analysis. Eur. Respir. J. 30, 508-516 (2007). (Pubitemid 351182075)
73. Song, Z. et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med. 201, 755-767 (2005). (Pubitemid 40395121)
74. Teirstein, A. S. Kveim antigen: What does it tell us about causation of sarcoidosis? Semin. Respir. Infect. 13, 206-211 (1998). (Pubitemid 28440839)
75. Ng, V. H., Cox, J. S., Sousa, A. O., MacMicking, J. D. & McKinney, J. D. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: Countering the phagocyte oxidative burst. Mol. Microbiol. 52, 1291-1302 (2004). (Pubitemid 38746304)
76. Zhang, Y., Garbe, T. & Young, D. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol. Microbiol. 8, 521-524 (1993). (Pubitemid 23156446)
77. Chen, E. S. et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J. Immunol. 181, 8784-8796 (2008).
78. Drake, W. P. et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect. Immun. 75, 527-530 (2007). (Pubitemid 46047932)
79. Dubaniewicz, A., Trzonkowski, P., Dubaniewicz-Wybieralska, M., Singh, M. & Mysliwski, A. Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: Comparison of sarcoidosis with tuberculosis and healthy controls. Respirology 12, 346-354 (2007). (Pubitemid 47164779)
80. Oswald-Richter, K. A. et al. Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis. Respir. Res. 11, 161 (2010).
81. Saltini, C. et al. M. avium binding to HLA-DR expressed alleles in silico: A model of phenotypic susceptibility to sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 25, 100-116 (2008).
82. Zhou, Y. et al. Differentiation of sarcoidosis from tuberculosis using real-Time PCR assay for the detection and quantification of Mycobacterium tuberculosis. Sarcoidosis Vasc. Diffuse Lung Dis. 25, 93-99 (2008).
83. Eishi, Y. et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J. Clin. Microbiol. 40, 198-204 (2002). (Pubitemid 34027624)
84. Ebe, Y. et al. Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 17, 256-265 (2000).
85. Nishiwaki, T. et al. Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am. J. Pathol. 165, 631-639 (2004). (Pubitemid 38971392)
86. McCaskill, J. G. et al. Pulmonary immune responses to Propionibacterium acnes in C57BL/6 and BALB/c mice. Am. J. Respir. Cell Mol. Biol. 35, 347-56 (2006). (Pubitemid 44353403)
87. Tchaptchet, S. et al. Innate, antigen-independent role for T cells in the activation of the immune system by Propionibacterium acnes. Eur. J. Immunol. 40, 2506-2516 (2010).
88. Wahlstrom, J. et al. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin. Immunol. 133, 353-363 (2009).
89. Munro, C. S. & Mitchell, D. N. The Kveim response: Still useful, still a puzzle. Thorax 42, 321-331 (1987). (Pubitemid 17070846)
90. Mana, J. et al. Löfgren's syndrome revisited: A study of 186 patients. Am. J. Med. 107, 240-245 (1999). (Pubitemid 29421590)
91. Tremblay, A., Stather, D. R., Maceachern, P., Khalil, M. & Field, S. K. A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest 136, 340-346 (2009).
92. Turner-Warwick, M., McAllister, W., Lawrence, R., Britten, A. & Haslam, P. L. Corticosteroid treatment in pulmonary sarcoidosis: Do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management? Thorax 41, 903-913 (1986). (Pubitemid 17213098)
93. Beirne, P. et al. Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. Eur. Respir. J. 34, 1376-1382 (2009).
94. Mana, J. Magnetic resonance imaging and nuclear imaging in sarcoidosis. Curr. Opin. Pulm. Med. 8, 457-463 (2002). (Pubitemid 34836953)
95. Bradley, B. et al. Interstitial lung disease guideline: The British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 63 (Suppl. 5), v1-v58 (2008).
96. Baughman, R. P. & Lower, E. E. Steroid-sparing alternative treatments for sarcoidosis. Clin. Chest Med. 18, 853-864 (1997). (Pubitemid 27525446)
97. Bachelez, H., Senet, P., Cadranel, J., Kaoukhov, A. & Dubertret, L. The use of tetracyclines for the treatment of sarcoidosis. Arch. Dermatol. 137, 69-73 (2001). (Pubitemid 32096360)
98. Park, M. K. et al. Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 26, 121-131 (2009).
99. Lower, E. E. & Baughman, R. P. The use of low dose methotrexate in refractory sarcoidosis. Am. J. Med. Sci. 299, 153-157 (1990). (Pubitemid 20085232)
100. Muller-Quernheim, J., Kienast, K., Held, M., Pfeifer, S. & Costabel, U. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur. Respir. J. 14, 1117-1122 (1999).
101. Moravan, M. & Segal, B. M. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 72, 337-340 (2009).
102. Majithia, V., Sanders, S., Harisdangkul, V. & Wilson, J. G. Successful treatment of sarcoidosis with leflunomide. Rheumatology (Oxford) 42, 700-702 (2003).
103. Baughman, R. P., Judson, M. A., Teirstein, A. S., Moller, D. R. & Lower, E. E. Thalidomide for chronic sarcoidosis. Chest 122, 227-232 (2002). (Pubitemid 34754167)
104. Doty, J. D., Mazur, J. E. & Judson, M. A. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 124, 2023-2026 (2003). (Pubitemid 37433608)
105. Judson, M. A. et al. Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial. Eur. Respir. J. 31, 1189-1196 (2008).
106. Utz, J. P. et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124, 177-185 (2003). (Pubitemid 36851350)
107. ClinicalTrials.gov. NIH [online], http://www.clinicaltrials.gov/ (2011).
108. Sharma, O. P. Vitamin D and sarcoidosis. Curr. Opin. Pulm. Med. 16, 487-488 (2010).
109. Lagana, S. M., Parwani, A. V. & Nichols, L. C. Cardiac sarcoidosis: A pathology-focused Review. Arch. Pathol. Lab. Med. 134, 1039- 1046 (2010).
110. Uemura, A. et al. Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. Am. Heart J. 138, 299-302 (1999). (Pubitemid 29379681)
111. Mehta, D. et al. Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing. Chest 133, 1426-1435 (2008). (Pubitemid 351893001)
112. Arcasoy, S. M. et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 120, 873-880 (2001). (Pubitemid 32885463)
113. Barnett, C. F. et al. Treatment of sarcoidosis-Associated pulmonary hypertension. A two-center experience. Chest 135, 1455-1461 (2009).
114. Nunes, H. et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 61, 68-74 (2006). (Pubitemid 43106981)
115. Keating, D. et al. Lung transplantation in pulmonary fibrosis: Challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years. Transplant. Proc. 41, 289-291 (2009).
116. Zaidi, A. R., Zaidi, A. & Vaitkus, P. T. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J. Heart Lung Transplant. 26, 714-717 (2007). (Pubitemid 47001719)
117. Scott, T. F., Yandora, K., Valeri, A., Chieffe, C. & Schramke, C. Aggressive therapy for neurosarcoidosis: long-Term follow-up of 48 treated patients. Arch. Neurol. 64, 691-696 (2007). (Pubitemid 46789835)
118. Voorter, C. E., Drent, M., Hoitsma, E., Faber, K. G. & van den Berg-Loonen, E. M. Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy. Sarcoidosis Vasc. Diffuse Lung Dis. 22, 129-132 (2005). (Pubitemid 41020018)
119. Chang, B. et al. Depression in sarcoidosis. Am. J. Respir. Crit. Care Med. 163, 329-334 (2001). (Pubitemid 32158507)
120. Goracci, A. et al. Quality of life, anxiety and depression in sarcoidosis. Gen. Hosp. Psychiatry 30, 441-445 (2008).